AVGO
1
-2
PAYX
29
-6
EQR
28
-3
AKAM
16
-2
AON
47
-9
PCG
45
-3
DHI
28
-7
AMZN
40
4
DLTR
38
7
ROST
47
-3
CINF
27
-4
DG
29
-2
DNB
28
-18
GT
28
-8
CVX
29
-2
QRVO
12
11
ORLY
40
-10
SJM
16
-7
LRCX
30
3
PPL
60
-7
AVGO
1
-2
PAYX
29
-6
EQR
28
-3
AKAM
16
-2
AON
47
-9
PCG
45
-3
DHI
28
-7
AMZN
40
4
DLTR
38
7
ROST
47
-3
CINF
27
-4
DG
29
-2
DNB
28
-18
GT
28
-8
CVX
29
-2
QRVO
12
11
ORLY
40
-10
SJM
16
-7
LRCX
30
3
PPL
60
-7
Financhill
Back

China Construction Bank Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
38

CICHF
China Construction Bank

Last Price:
$0.82
Seasonality Move:
-1.4%
Sell
46

SRPT
Sarepta Therapeutics

Last Price:
$49.31
Seasonality Move:
15.14%
Sell
38
China Construction Bank (CICHF) is a Sell

Is China Construction Bank a Buy, Sell or Hold?

  • The current China Construction Bank [CICHF] share price is $0.83. The Score for CICHF is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CICHF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $52.40. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CICHF Stock Price Chart

What is China Construction Bank's stock price today?

  • The China Construction Bank share price today is $0.83
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CICHF is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $52.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.

CICHF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 42.37 Sell
Chaikin Money Flow: 1876 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.84 - 0.9) Sell
Bollinger Bands (100): (0.76 - 0.86) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -12.34 Sell
Relative Strength Index (14 RSI): 18.92 Sell
Chaikin Money Flow: -892579 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (63.69 - 99.33) Sell
Bollinger Bands (100): (89.45 - 127.95) Sell

CICHF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.86 Sell
20-day SMA: 0.87 Sell
50-day SMA: 0.84 Sell
200-day SMA: 0.77 Buy
8-day EMA: 0.86 Sell
20-day EMA: 0.86 Sell
50-day EMA: 0.85 Sell
200-day EMA: 0.77 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.98 Sell
20-day SMA: 75.86 Sell
50-day SMA: 96.45 Sell
200-day SMA: 122.02 Sell
8-day EMA: 61.32 Sell
20-day EMA: 73.51 Sell
50-day EMA: 90.64 Sell
200-day EMA: 112.83 Sell

China Construction Bank Earnings Growth & CICHF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.39 per share, a decrease next quarter of $0.51 per share, an increase this year of $5.06 per share, and an increase next year of $5.37 per share.

China Construction Bank Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):